Condition: Pseudomonas Aeruginosa · Multi-antibiotic Resistance · Sponsor: University Hospital, Grenoble
Pseudomonas aeruginosa is a pathogenic bacteria for human, especially in hospital settings. It can sometimes be multi-resistant to many or even to all antibiotics usually used for its treatment. The aim of the study is to isolate and produce therapeutic antibodies against the bacteria Pseudomonas aeruginosa in order to provide an alternative treatment to antibiotics in case of infection with an antibiotic-resistant strain of Pseudomonas aeruginosa.
This description comes directly from the study's public registry record.
Yvan CASPAR, Dr · +33 4 76 76 54 79 · ycaspar@chu-grenoble.fr
Always discuss trial participation with your own doctor first.
| Chu Grenoble Alpes | Grenoble, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04335383